Health

  • October 27, 2025

    Colo. Doctor Sues Ex-Employer For Disability Discrimination

    A Colorado emergency physician has filed a discrimination lawsuit against his former employer, alleging the healthcare provider terminated him because of his disability and accommodation requests.

  • October 27, 2025

    Pa. Hospital Workers Seek Initial Approval For OT Suit Deal

    A health system agreed to a $70,000 deal to end a proposed class action alleging it failed to pay unionized hospital workers proper overtime wages, according to an unopposed motion for preliminary approval that the workers filed in Pennsylvania federal court Friday.

  • October 27, 2025

    Judge Tosses Eli Lilly Suit Over Telehealth Weight Loss Drugs

    A California federal court has dismissed a lawsuit from Eli Lilly against a telehealth company and related entities over the compounding of its popular weight loss drugs Mounjaro and Zepbound, saying the pharmaceutical giant's complaint failed to plausibly allege claims under the Lanham Act and the state's false advertising and consumer protection laws.

  • October 27, 2025

    Biotech Firm MapLight Inks $251M IPO Amid Shutdown

    Biotechnology company MapLight Therapeutics began trading publicly Monday after raising $251 million in its initial public offering, which marked a rare listing during the ongoing federal government shutdown.

  • October 27, 2025

    Ex-Magellan CEO Avoids Prison Over Faulty Lead Tests

    The former CEO of Magellan Diagnostics was sentenced in Massachusetts federal court Monday to a year of home confinement for failing to alert regulators to a problem in the company's lead-testing devices that resulted in inaccurately low lead levels being detected in blood samples.

  • October 24, 2025

    Gordon Rees 'Profoundly Embarrassed' By Atty's AI Mistakes

    Gordon Rees Scully Mansukhani LLC has apologized to an Alabama bankruptcy court for a filing submitted by one of its lawyers that contained mistakes it blamed on artificial intelligence, saying it's "profoundly embarrassed" by the incident and will accept whatever sanctions end up being issued.

  • October 24, 2025

    Calif. Dialysis Bill Violates Free Speech, 9th Circ. Told

    Attorneys for healthcare providers, dialysis patients and a charity urged the Ninth Circuit in a Friday hearing to reverse a district court ruling upholding part of a California law capping profits for dialysis providers that donate to a charitable fund that then supports insurance payments for the providers' patients.

  • October 24, 2025

    Curaleaf Urges Block On NJ Pot Shop Union Rule

    Curaleaf asked a New Jersey federal judge Friday to block state cannabis industry regulators from making cannabis retailers sign labor peace agreements with unions, saying the requirement treads on the retailers' rights under the National Labor Relations Act.

  • October 24, 2025

    Pfizer Hit With More Suits Over Depo-Provera

    Three women sued Pfizer this week in Florida federal court, alleging its hormonal contraceptive birth control shot Depo-Provera caused their brain tumors in the latest claims that the major drugmaker failed to warn of the link.

  • October 24, 2025

    USAA Defends Medical Reimbursement Cuts In Coverage Row

    Two USAA units sought to toss two insureds' proposed class action accusing the companies of under-reimbursing their medical providers via claim handling software, telling a Washington federal court "there is no admissible evidence that plaintiffs' treatments were medically necessary and related to their auto accidents."

  • October 24, 2025

    2 Texas Justices Say Qui Tam Constitutionality Needs Review

    The Texas Supreme Court has rejected a bid from Novartis Pharmaceuticals Corp. to examine the constitutionality of state law-based qui tam claims, but on Friday two justices submitted a statement saying the court will have to address the issue eventually.

  • October 24, 2025

    3rd Circ. Revives Nonprofit's Bias Suit Over Permit Denial

    The Third Circuit on Friday revived an alcohol and substance abuse recovery nonprofit's disability bias suit against a New Jersey town, reasoning that the district court improperly denied the plaintiff the opportunity to refine its allegations that the municipality denied it a permit based on the nature of its operation.

  • October 24, 2025

    Mich. Patients, Doctors Fight Pregnancy End-Of-Life Carveout

    A group of Michigan couples and doctors has sued to challenge a Michigan law that prevents medical professionals and family members from honoring the end-of-life medical care decisions of pregnant women who refuse life-sustaining care.

  • October 24, 2025

    LifeScan Urges Court To Force PBMs To Produce Documents

    Glucose monitor maker LifeScan has asked a Texas bankruptcy judge to force pharmacy benefit managers to produce documents amid a dispute over administrative expense claims in the Chapter 11 case, saying PBMs including OptumRx and Caremark are using delay as "sword and shield."

  • October 24, 2025

    Hagens Berman Wants Judge DQ, Alleges Drug Lawsuit Bias

    Hagens Berman Sobol Shapiro LLP asserted Friday that the Pennsylvania federal judge overseeing the long-running thalidomide birth-defect litigation in the state should be recused, alleging over 100 undisclosed private contacts between the court and special discovery master as an indication of bias.

  • October 24, 2025

    NFL Players' Race Bias Claims Tossed In Concussion Case

    A Pennsylvania federal judge on Friday denied a motion by a group of 16 former football players who claimed that they were wrongly denied benefits under the National Football League's 2015 concussion injury settlement.

  • October 24, 2025

    Generic-Drug Makers Want Conn. Price Cap Blocked During Suit

    A trade group for generic and biosimilar drugmakers is asking a Connecticut federal judge to block the state's new drug price cap during the pendency of its challenge, saying it illegally controls prices on sales made outside the state.

  • October 24, 2025

    Eli Lilly Buying Eye Disease Biotech For Up To $262M

    Ropes & Gray LLP-advised Eli Lilly said Friday it has agreed to acquire Cooley LLP-guided Adverum Biotechnologies, a clinical-stage company developing gene therapies for eye diseases, for up to roughly $262 million. 

  • October 24, 2025

    Taxation With Representation: Latham, Wachtell, Gibson Dunn

    In this week's Taxation With Representation, Meta announces a joint venture with Blue Owl Capital to fund the development of a data center campus in Louisiana, private equity giants acquire medical technology company Hologic Inc., and National Fuel Gas Co. buys CenterPoint Energy Inc.'s Ohio natural gas utility business.

  • October 24, 2025

    Senior Care Exec Says CEO's Estate Must Repay $1.5M Loan

    A Florida man who worked as chief business development officer for Connecticut's Maplewood Senior Living LLC says the estate of the organization's deceased CEO owes nearly $1.5 million on a 2016 loan that he previously refused to collect due to a personal friendship.

  • October 24, 2025

    Paramedics Can't Use Mich. Law To Escape Negligence Suit

    Evidence suggesting paramedics may have forged a patient's signature declining hospital transport for COVID-19 care and purported statements that responders didn't bring him in because hospitals were full are enough to overcome a state law that gives immunity to emergency responders, a Michigan appellate panel has determined.

  • October 23, 2025

    Wash. Justices Skeptical Of Debtor's Collection Notice Stance

    Washington Supreme Court justices appeared wary Thursday of second-guessing a Seattle federal judge who asked them to decide whether a hospital billing disclosure law applies to debt collectors, as the plaintiff in the underlying proposed class action pressed the court to "reformulate" the certified question.  

  • October 23, 2025

    9th Circ. Calls For Evidence Hearing Over ICE Facility Access

    The Ninth Circuit on Thursday partially remanded the Washington State Department of Health's lawsuit accusing GEO Group of illegally blocking access to an immigration facility for safety inspections, calling for an evidentiary hearing into how the refusal for access played out.

  • October 23, 2025

    6th Circ. Panel Torn On Mich. 'Conversion Therapy' Ban

    A Sixth Circuit panel appeared divided Thursday about whether to block enforcement of Michigan's ban on conversion therapy for minors as the U.S. Supreme Court grapples with a nearly identical Colorado law.

  • October 23, 2025

    NextGen Customers Seek Initial OK Of $19M Data Hack Deal

    A Georgia federal judge was asked Wednesday to grant preliminary approval of a settlement that would end a proposed class action against NextGen Healthcare over a 2023 data hack that allegedly affected more than 1 million people.

Expert Analysis

  • Calif. Bill May Shake Up Healthcare Investment Landscape

    Author Photo

    If signed by the governor, newly passed California legislation would significantly expand the Office of Health Care Affordability's oversight of private equity and hedge fund investments in healthcare companies and management services organizations, and raise several questions about companies' data confidentiality and filing burdens, say attorneys at Ropes & Gray.

  • How Hyperlinks Are Changing E-Discovery Responsibilities

    Author Photo

    A recent e-discovery dispute over hyperlinked data in Hubbard v. Crow shows how courts have increasingly broadened the definition of control to account for cloud-based evidence, and why organizations must rethink preservation practices to avoid spoliation risks, says Bree Murphy at Exterro.

  • Pharma Copay Programs Raise Complex Economic Questions

    Author Photo

    The growing prevalence of copay accumulator and maximizer programs in the pharmaceutical industry is drawing increased scrutiny from patients, advocacy groups, lawmakers and courts, bringing complex questions about how financial responsibility for prescription drug purchases is determined and complicating damages assessments in litigation, say analysts at Analysis Group.

  • State False Claims Acts Can Help Curb Opioid Fund Fraud

    Author Photo

    State versions of the federal False Claims Act can play an important role in policing the misuse of opioid settlement funds, taking a cue from the U.S. Department of Justice’s handling of federal fraud cases involving pandemic relief funds, says Kenneth Levine at Stone & Magnanini.

  • 'Occurrence' Lessons From Policyholder's COVID Ruling Win

    Author Photo

    The Minnesota Court of Appeals recently handed policyholders an important win in Life Time v. Zurich American Insurance, reversing a trial court ruling that had capped coverage under a communicable disease endorsement at a single occurrence, showing the importance of fact-specific inquiry, say attorneys at Hunton.

  • Series

    Writing Musicals Makes Me A Better Lawyer

    Author Photo

    My experiences with writing musicals and practicing law have shown that the building blocks for both endeavors are one and the same, because drama is necessary for the law to exist, says Addison O’Donnell at LOIS Law.

  • Series

    Adapting To Private Practice: From Va. AUSA To Mid-Law

    Author Photo

    Returning to the firm where I began my career after seven years as an assistant U.S. attorney in Virginia has been complex, nuanced and rewarding, and I’ve learned that the pursuit of justice remains the constant, even as the mindset and client change, says Kristin Johnson at Woods Rogers.

  • Transmission Security Has A Critical Role In Healthcare

    Author Photo

    In light of the U.S. Department of Health and Human Services' Office of Civil Rights' continuing enforcement initiative focusing on businesses' accurate and thorough security risk assessments under the Health Insurance Portability and Accountability Act, covered entities should not neglect the importance of transmission security, says John Howard at Clark Hill.

  • Rebutting Price Impact In Securities Class Actions

    Author Photo

    Defendants litigating securities cases historically faced long odds in defeating class certification, but that paradigm has recently begun to shift, with recent cases ushering in a more searching analysis of price impact and changing the evidence courts can consider at the class certification stage, say attorneys at Katten.

  • 7 Document Review Concepts New Attorneys Need To Know

    Author Photo

    For new associates joining firms this fall, stepping into the world of e-discovery can feel like learning a new language, but understanding a handful of fundamentals — from coding layouts to metadata — can help attorneys become fluent in document review, says Ann Motl at Bowman and Brooke.

  • FTC Actions Highlight New Noncompete Enforcement Strategy

    Author Photo

    Several recent noncompete-related actions from the Federal Trade Commission — including its recent dismissal of cases appealing the vacatur of a Biden-era noncompete ban — reflect the commission's shift toward case-by-case enforcement, while confirming that the agency intends to remain active in policing such agreements, say attorneys at Debevoise.

  • Ruling On Labor Peace Law Marks Shift For Cannabis Cos.

    Author Photo

    Currently on appeal to the Ninth Circuit, an Oregon federal court’s novel decision in Casala v. Kotek, invalidating a state law that requires labor peace agreements as a condition of cannabis business licensure, marks the potential for compliance uncertainty for all cannabis employers in states with labor peace mandates, say attorneys at Sheppard Mullin.

  • Deference Ruling Could Close The FAR Loophole

    Author Photo

    A recent U.S. Court of Federal Claims decision may close a loophole in the Federal Acquisition Regulation that allows agencies to circumvent the Trade Agreements Act, significantly affecting federal pharmaceutical procurements and increasing protests related to certain Buy American Act waivers, say attorneys at Polsinelli.

  • Agentic AI Puts A New Twist On Attorney Ethics Obligations

    Author Photo

    As lawyers increasingly use autonomous artificial intelligence agents, disciplinary authorities must decide whether attorney responsibility for an AI-caused legal ethics violation is personal or supervisory, and firms must enact strong policies regarding agentic AI use and supervision, says Grace Wynn at HWG.

  • When AI Denies, Insurance Bad Faith Claims May Follow

    Author Photo

    Two recent rulings from Minnesota and Kentucky federal courts signal that past statements about claims-handling practices may leave insurers using artificial intelligence programs in claims administration vulnerable to suits alleging bad faith and unfair trade practices, say attorneys at Cozen O'Connor.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.